This is further enhanced by infiltration of CXCR1- or CXCR2-expressing MDSCs, which further promote tumor growth by inhibiting local anti-tumor immune responses mediated by CD8+ T-lymphocyte infiltration and cytotoxicity. The gene discussed is CXCR2; the disease is neoplasm.